Protection of Mice Against Staphylococcus Aureus Infection by a Recombinant Protein Clfa–Isdb–Hlg As a Vaccine Candidate Publisher Pubmed



Delfani S¹ ; Mohabati Mobarez A¹ ; Imani Fooladi AA² ; Amani J² ; Emaneini M³ Show Affiliations
Source: Medical Microbiology and Immunology Published:2016

Abstract

Staphylococcus aureus is one of the most important causes of nosocomial infections. An effective vaccine to prevent S. aureus infections is urgently required due to the dramatic increase in the number of antibiotic-resistant strains. In this report, we evaluated a newly recombinant protein composed of selected antigenic regions of clumping factor A (ClfA), iron surface determinant B (IsdB) and gamma hemolysin B (HlgB) of S. aureus and sequence coding for hydrophobic linkers between three domains. The recombinant gene was constructed in pET-28a (+) and expressed in Escherichia coli BL21. In addition, sequence coding for a His6-tag was added followed by a hybrid procedure of nickel chelate protein purification. Immunization of BALB/c mice with the recombinant protein ClfA–IsdB–Hlg evoked antigen-specific antibodies that could opsonize S. aureus cells, enhancing in vitro phagocytosis by macrophages. Vaccination with the recombinant protein also reduced the bacterial load recovered from mice spleen samples and increased survival following the intraperitoneal challenge with pathogenic S. aureus compared to the control mice. Our results showed that the recombinant protein ClfA–IsdB–Hlg is a promising vaccine candidate for the prevention of S. aureus bacteremia infections. © 2015, Springer-Verlag Berlin Heidelberg.